| Authors: |
Heitmann JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Maringer Y; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Jung S; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Wacker M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Hackenbruch C; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany., Polster M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany; Department of Computer Science, University of Tübingen, Tübingen, Germany., Marconato M; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany., Nelde A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Bauer J; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Zwick M; Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany., Baur AS; Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany; CIBSS-Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany; Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany., Metzger A; Faculty of Biology, Albert-Ludwigs-Universität, Freiburg, Germany; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Krolla C; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center-University of Freiburg, Freiburg, Germany., Andrieux G; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Köhler N; Department of Internal Medicine I, Medical Center-University of Freiburg, Faculty of Medicine, Albert Ludwigs University, Freiburg, Germany; CIBSS-Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany., Boerries M; Institute of Medical Bioinformatics and Systems Medicine, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; German Cancer Consortium (DKTK), Partner site Freiburg, a partnership between DKFZ and Medical Center-University of Freiburg, Freiburg, Germany., Denk M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany., Zieschang L; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany., Kammer C; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Hoenisch-Gravel N; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Richter M; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany., Oezbek MT; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Wirths S; Department of Internal Medicine II, Hematology, Oncology, Clinical Immunology, and Rheumatology, University Hospital Tübingen, Tübingen, Germany., Dengler A; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany., Dubbelaar ML; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany; Quantitative Biology Center (QBiC), University of Tübingen, Tübingen, Germany., Pumptow M; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany., Martus P; Institute for Clinical Epidemiology and Applied Biometry, University Hospital Tübingen, Tübingen, Germany., Brüggemann M; Department of Hematology and Oncology, University Hospital Schleswig-Holstein Campus, Kiel, Germany., Rammensee HG; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany; Institute of Immunology, University of Tübingen, Tübingen, Germany., Salih HR; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany., Walz JS; Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany; Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany; Cluster of Excellence iFIT (EXC2180): Image-Guided and Functionally Instructed Tumor Therapies, University of Tübingen, Tübingen, Germany; German Cancer Consortium (DKTK), partner site Tübingen, partnership between German Cancer Research Center (DKFZ) and University Hospital Tübingen, Tübingen, Germany. Electronic address: juliane.walz@med.uni-tuebingen.de. |
